Agenda

Session Introduction

‍

Transforming Outcomes in Metastatic HER2-Postive Breast Cancer

‍

CNS Metastases in HER2-Positive Breast Cancer: Closing the Therapeutic Gap

‍

The Balancing Act: Endocrine Meets HER2 in Triple-Positive Disease

‍

Audience Q&A and Panel Discussion